Quick Answer
Twist Bioscience Corp reported Cash and Equivalents of $183.05 million for fiscal year 2025.
Twist Bioscience Corp Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $183.05M | -19.1% |
| 2024 | $226.32M | -21.0% |
| 2023 | $286.47M | -24.4% |
| 2022 | $378.69M | -18.7% |
| 2021 | $465.83M | +397.3% |
| 2020 | $93.67M | +100.4% |
| 2019 | $46.73M | -42.1% |
| 2018 | $80.76M | +158.6% |
| 2017 | $31.23M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $148.59M | -32.9% | -18.8% |
| September 30, 2025 | $183.05M | -19.1% | -9.1% |
| June 30, 2025 | $201.37M | -15.8% | -4.3% |
| March 31, 2025 | $210.44M | -13.5% | -5.0% |
| December 31, 2024 | $221.40M | -16.8% | -2.2% |
| September 30, 2024 | $226.32M | -21.0% | -5.4% |
| June 30, 2024 | $239.14M | -22.2% | -1.7% |
| March 31, 2024 | $243.35M | -22.8% | -8.6% |
- Twist Bioscience Corp showed a decrease of -19.1% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, Twist Bioscience Corp’s cash and equivalents has grown by 486.2% (from $31.23 million to $183.05 million).
- The most recent figure is from Twist Bioscience Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on November 17, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: